FDA — authorised 8 February 1957
- Marketing authorisation holder: PARKE DAVIS
- Status: approved
🇺🇸 Celontin in United States
FDA authorised Celontin on 8 February 1957
Marketing authorisations
FDA — authorised 8 February 1957
- Application: NDA010596
- Marketing authorisation holder: PARKE DAVIS
- Local brand name: CELONTIN
- Indication: CAPSULE — ORAL
- Status: approved
Celontin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Celontin approved in United States?
Yes. FDA authorised it on 8 February 1957; FDA authorised it on 8 February 1957.
Who is the marketing authorisation holder for Celontin in United States?
PARKE DAVIS holds the US marketing authorisation.